找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 2020Latest edition Springer Nature Switzerland AG 2020 Hodgkin Lymph

[复制链接]
查看: 36716|回复: 57
发表于 2025-3-21 19:57:41 | 显示全部楼层 |阅读模式
书目名称Hodgkin Lymphoma
副标题A Comprehensive Over
编辑Andreas Engert,Anas Younes
视频video
概述Examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma.Reviews the emerging individually tailored treatment strategies.Covers pathogenesis, clinical
丛书名称Hematologic Malignancies
图书封面Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 2020Latest edition Springer Nature Switzerland AG 2020 Hodgkin Lymph
描述.This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of .Hodgkin Lymphoma: A Comprehensive Overview. has been revised and updated by key opinion leaders to reflect recent progressin the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma..
出版日期Book 2020Latest edition
关键词Hodgkin Lymphoma; Radiation Therapy for Hodgkin Lymphoma; Chemotherapy in Hodgkin Lymphoma; Paediatric
版次3
doihttps://doi.org/10.1007/978-3-030-32482-7
isbn_softcover978-3-030-32484-1
isbn_ebook978-3-030-32482-7Series ISSN 2197-9766 Series E-ISSN 2197-9774
issn_series 2197-9766
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

书目名称Hodgkin Lymphoma影响因子(影响力)




书目名称Hodgkin Lymphoma影响因子(影响力)学科排名




书目名称Hodgkin Lymphoma网络公开度




书目名称Hodgkin Lymphoma网络公开度学科排名




书目名称Hodgkin Lymphoma被引频次




书目名称Hodgkin Lymphoma被引频次学科排名




书目名称Hodgkin Lymphoma年度引用




书目名称Hodgkin Lymphoma年度引用学科排名




书目名称Hodgkin Lymphoma读者反馈




书目名称Hodgkin Lymphoma读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:58:27 | 显示全部楼层
Pathology and Molecular Pathology of Hodgkin Lymphoma pattern of their cellular origin. HRS cells show an activation of numerous signaling pathways, and particularly the NF-κB and JAK/STAT pathways are often constitutively activated through genetic lesions. Other genetic lesions contribute to immune evasion of the HRS cells.
发表于 2025-3-22 03:02:02 | 显示全部楼层
Microenvironment, Cross-Talk, and Immune Escape Mechanismsemploy a variety of immune escape mechanisms with a central role for antigen presentation through the human leukocyte antigen and associated immune checkpoints. Given the different pathogenetic functions of different cell types in the microenvironment, we end with reviewing data on the prognostic impact of the abundance of specific cell types.
发表于 2025-3-22 06:40:35 | 显示全部楼层
Treatment of Early Unfavorable Hodgkin Lymphoman incorporated into clinical trials. This chapter will give you an overview on the recent and current treatment approaches and will highlight the discussion on PET-guided treatment and new drugs in this setting.
发表于 2025-3-22 10:05:16 | 显示全部楼层
发表于 2025-3-22 16:23:42 | 显示全部楼层
Book 2020Latest editioniate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially ap
发表于 2025-3-22 17:31:21 | 显示全部楼层
发表于 2025-3-22 23:03:42 | 显示全部楼层
https://doi.org/10.1007/978-3-030-32482-7Hodgkin Lymphoma; Radiation Therapy for Hodgkin Lymphoma; Chemotherapy in Hodgkin Lymphoma; Paediatric
发表于 2025-3-23 02:56:58 | 显示全部楼层
发表于 2025-3-23 05:51:24 | 显示全部楼层
Hodgkin Lymphoma978-3-030-32482-7Series ISSN 2197-9766 Series E-ISSN 2197-9774
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 12:21
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表